All Pharma News
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets
GLOBENEWSWIRE
26 Dec 2023
Share Share
Atreca cuts head count by 40% for 2nd time in 3 months

Atreca cuts head count by 40% for 2nd time in 3 months
Nick Paul Taylor FIERCE BIOTECH
15 Nov 2023
Share Share
Atreca Reports Third Quarter 2023 Financial Results

Atreca Reports Third Quarter 2023 Financial Results
GLOBENEWSWIRE
14 Nov 2023
Share Share
Atreca Announces Agreement to Terminate Lease

Atreca Announces Agreement to Terminate Lease
GLOBENEWSWIRE
21 Sep 2023
Share Share
Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs

Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs
Nick Paul Taylor FIERCE BIOTECH
11 Aug 2023
Share Share
Atreca holds off development on its only clinical program, cuts headcount by 40%

Atreca holds off development on its only clinical program, cuts headcount by 40%
Reynald Castañeda ENDPTS
11 Aug 2023
Share Share
Atreca Reports Second Quarter 2023 Financial Results

Atreca Reports Second Quarter 2023 Financial Results
GLOBENEWSWIRE
10 Aug 2023
Share Share
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101

Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101
GLOBENEWSWIRE
05 Jun 2023
Share Share
Atreca Reports 1Q 2023 Financial Results and Recent Corporate Developments

Atreca Reports 1Q 2023 Financial Results and Recent Corporate Developments
GLOBENEWSWIRE
10 May 2023
Share Share
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at 2023 ASCO

Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at 2023 ASCO
GLOBENEWSWIRE
26 Apr 2023
Share Share